Jpmorgan Chase & CO Surmodics Inc Transaction History

Jpmorgan Chase & CO

$1.23 Trillion
Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Surmodics Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 50,990 shares of SRDX stock, worth $1.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,990

Previous 42,470 20.06%

Holding current value

$1.74 Million

Previous $1.65 Million 22.66%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$37.5 - $40.13 $319,500 - $341,907	8,520 Added 20.06%	50,990 $2.02 Million
Q3 2024 Dec 26, 2024	BUY	$38.47 - $42.24 $1.08 Million - $1.18 Million	27,960 Added 192.69%	42,470 $1.65 Million
Q3 2024 Nov 08, 2024	BUY	$38.47 - $42.24 $1.08 Million - $1.18 Million	27,960 Added 192.69%	42,470 $1.65 Million
Q2 2024 Dec 26, 2024	SELL	$25.39 - $42.1 $709,904 - $1.18 Million	-27,960 Reduced 65.83%	14,510 $610,000
Q2 2024 Aug 12, 2024	SELL	$25.39 - $42.1 $305,010 - $505,747	-12,013 Reduced 45.29%	14,510 $610,000
Q1 2024 Dec 26, 2024	SELL	$27.44 - $35.56 $437,585 - $567,075	-15,947 Reduced 37.55%	26,523 $778,000
Q1 2024 May 10, 2024	BUY	$27.44 - $35.56 $334,850 - $433,938	12,203 Added 85.22%	26,523 $778,000
Q4 2023 Dec 26, 2024	SELL	$28.47 - $38.49 $801,430 - $1.08 Million	-28,150 Reduced 66.28%	14,320 $520,000
Q4 2023 Feb 12, 2024	BUY	$28.47 - $38.49 $74,619 - $100,882	2,621 Added 22.4%	14,320 $520,000
Q3 2023 Nov 14, 2023	SELL	$28.28 - $38.36 $35,745 - $48,487	-1,264 Reduced 9.75%	11,699 $375,000
Q2 2023 Aug 11, 2023	SELL	$17.67 - $31.31 $29,508 - $52,287	-1,670 Reduced 11.41%	12,963 $405,000
Q1 2023 May 18, 2023	BUY	$17.13 - $38.52 $178,871 - $402,225	10,442 Added 249.15%	14,633 $333,000
Q1 2023 May 11, 2023	SELL	$17.13 - $38.52 $153,005 - $344,060	-8,932 Reduced 68.06%	4,191 $95,000
Q4 2022 Feb 13, 2023	BUY	$29.44 - $37.31 $28,085 - $35,593	954 Added 7.84%	13,123 $449,000
Q3 2022 Nov 14, 2022	BUY	$28.84 - $38.92 $21,082 - $28,450	731 Added 6.39%	12,169 $369,000
Q2 2022 Aug 11, 2022	BUY	$33.25 - $45.11 $41,196 - $55,891	1,239 Added 12.15%	11,438 $426,000
Q1 2022 May 11, 2022	SELL	$40.68 - $49.72 $70,213 - $85,816	-1,726 Reduced 14.47%	10,199 $462,000
Q4 2021 Feb 10, 2022	SELL	$43.21 - $57.6 $18,882 - $25,171	-437 Reduced 3.54%	11,925 $574,000
Q3 2021 Nov 12, 2021	BUY	$52.8 - $60.32 $652,713 - $745,675	12,362 New	12,362 $687,000

Others Institutions Holding SRDX

# of Institutions

141

Shares Held

12M

Call Options Held

31.4K

Put Options Held

13.2K

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $477M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Surmodics Inc Transaction History